Abant Izzet Baysal University Faculty of Health Science
Bolu, 14100, Turkey (Türkiye)
Location status: Recruiting
NCT Number: NCT07247773
The Cybersickness in Virtual Reality Questionnaire (CSQ-VR) is a tool designed to measure the presence and intensity of cybersickness symptoms experienced in VR. The CSQ-VR is an adapted and improved version of the Cybersickness section of the Virtual Reality Neuroscience Questionnaire (VRNQ). The aim of this study is to examine the validity and reliability of the Turkish version of the CSQ-VR.
Interested in participating?
Request Info18 year–30 year
All sexes
Observational
Bolu, 14100, Turkey (Türkiye)
Location status: Recruiting
Alongside the many innovations brought by virtual reality, some users may experience the phenomenon of cybersickness. Symptoms of cybersickness include nausea, disorientation, and oculomotor disturbances. Although cybersickness shares similarities with simulator sickness, it differs in terms of the frequency and severity of symptoms. In particular, users who experience cybersickness report increased overall discomfort due to nausea and disorientation. Cybersickness is also distinct from motion sickness, as cybersickness is triggered by visual stimulation, whereas motion sickness is induced by actual physical movement.
Although there is no comprehensive theoretical framework for cybersickness, the most common and dominant explanation is the sensory conflict theory. This framework suggests that the symptomatology of cybersickness arises from a sensory conflict between the vestibular (inner ear) and visual systems. Simply put, the perception of postural balance depends on a combination of visual, vestibular, and proprioceptive inputs. It is assumed that conflicting motion perception cues from these systems cause cybersickness. The technological source of this conflict is vection, an illusory sense of self-motion induced in VR. Vection is considered one of the main causes of cybersickness in VR. In particular, movements such as linear and angular accelerations are reported to provoke cybersickness in users.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Immediately after a single VR session (~1 hour)
It is a tool designed to measure the presence and severity of cybersickness symptoms experienced in VR
Time frame: Immediately after a single VR session (~1 hour)
The Simulator Sickness Questionnaire evaluates 16 symptoms such as eye strain, nausea, sweating, and headache, each rated on four severity levels (none, slight, moderate, and severe).
Abant Izzet Baysal University
Other
Turkish Validity and Reliability of CyberSickness in Virtual Reality Questionnaire
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07706686
Arbovirus Infections, Dengue
Bethesda, Maryland, United States
View Trial DetailsNCT06552754
Healthy Volunteers, Virtual Reality
Ames, Iowa, United States
View Trial DetailsNCT07735949
Foot Biomechanics, Healthy Volunteers
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02446262
Healthy Volunteers, Neurologic Manifestations
Bethesda, Maryland, United States
View Trial Details